Yes BOT making huge strides thus far and quietly confident Permetrex will deliver cashflows in the not too distant future which would be a remarkable outcome for a biotech listed less than 12 months.
Ann: American Academy of Dermatology Annual Meeting Presentation, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.8¢ |
Change
-0.008(4.55%) |
Mkt cap ! $308.8M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.3¢ | 15.5¢ | $1.050M | 6.587M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 3062895 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2422395 | 24 |
View Market Depth
| Last trade - 11.10am 30/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |